4//SEC Filing
Mahadevia Ankit 4
Accession 0000950170-25-014849
CIK 0001701108other
Filed
Feb 4, 7:00 PM ET
Accepted
Feb 5, 8:30 PM ET
Size
6.9 KB
Accession
0000950170-25-014849
Insider Transaction Report
Form 4
Mahadevia Ankit
Director
Transactions
- Sale
Common Stock
2025-02-05$0.78/sh−13,959$10,888→ 745,126 total - Sale
Common Stock
2025-02-05$0.78/sh−55,260$43,103→ 689,866 total
Footnotes (3)
- [F1]The reported transaction is a sale of common stock effected to cover tax withholding obligations pursuant to a "sell to cover" provision included in each RSU Agreement in connection with the vesting of RSUs that were granted to the Reporting Person on February 1, 2022.
- [F2]Amount includes 65,817 shares of common stock held by the Mahadevia-Mehta Family Trust, of which the Reporting Person is a trustee.
- [F3]The reported transaction is a sale of common stock effected to cover tax withholding obligations pursuant to a "sell to cover" provision included in each RSU Agreement in connection with the vesting of RSUs that were granted to the Reporting Person on February 1, 2023.
Documents
Issuer
Spero Therapeutics, Inc.
CIK 0001701108
Entity typeother
Related Parties
1- filerCIK 0001720974
Filing Metadata
- Form type
- 4
- Filed
- Feb 4, 7:00 PM ET
- Accepted
- Feb 5, 8:30 PM ET
- Size
- 6.9 KB